Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non–small cell lung cancer: exploratory analysis of a prospective observational study

Lung Cancer 2026

View at publisher
Authors: Takashi Kurosaki, Shinichiro Suzuki, Yasutaka Watanabe, Hirotsugu Kenmotsu, Shoichi Itoh, Masafumi Yamaguchi, Ayako Shiono, Takuji Suzuki, Toshihide Yokoyama, Yukihiro Toi, Hisashi Tanaka, Masahide Oki
+9 more Takeshi Tsuda, Eiki Ichihara, Koichi Azuma, Hiroshi Tanaka, Ryo Arai, Ken Uchibori, Eisaku Miyauchi, Ryohei Katayama, Hidetoshi Hayashi
DOI: 10.1016/j.lungcan.2026.109416
Cited by: 1
References: 44

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

Publication details

Journal / source
Lung Cancer
Publisher
Elsevier BV
Volume
216
Pages
109416–109416
Publication date
19 April 2026
Language
EN